10th week of 2017 patent applcation highlights part 8

Patent application number	Title	Published
10th week of 2017 patent applcation highlights part 8
20170065603	Novel 2,5-substituted pyrimidines	2017-03-09
20170065604	C5aR ANTAGONISTS	2017-03-09
20170065605	TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE	2017-03-09
20170065606	AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF	2017-03-09
20170065607	METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS	2017-03-09
20170065608	PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN ASSOCIATED WITH GUILLAIN-BARRE SYNDROME	2017-03-09
20170065609	ANTICANCER AGENT COMPOSITION	2017-03-09
20170065610	COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE	2017-03-09
20170065611	TOPICAL FORMULATIONS AND USES THEREOF	2017-03-09
20170065612	Hypotensive lipid-containing biodegradable intraocular implants and related implants	2017-03-09
20170065613	Non-Systemic Topical Compositions Comprising Corticosteroids	2017-03-09
20170065614	PROLIPOSOMAL TESTOSTERONE FORMULATIONS	2017-03-09
20170065615	Steroid Analogues for Neuroprotection	2017-03-09
20170065616	Serum Cholesterol Lowering Edible Product	2017-03-09
20170065617	Compositions and Methods to Treat Vision Disorders	2017-03-09
20170065618	PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND A CORTICOSTEROID	2017-03-09
20170065619	TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING NANODROPLETS FOR THE TREATMENT OF PSORIASIS	2017-03-09
20170065620	OSTEOCLAST INHIBITORS FOR KNEE CONDITIONS	2017-03-09
20170065621	CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT PAIN	2017-03-09
20170065622	COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME	2017-03-09
20170065623	COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME	2017-03-09
20170065624	COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID ORRELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAINSYNDROME	2017-03-09
20170065625	DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE	2017-03-09
20170065626	COMPOSITIONS AND METHODS OF TREATING OF BACTERIAL INFECTIONS WITH BETA-LACTAMASE INHIBITORS	2017-03-09
20170065627	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF COGNITIVE FUNCTION DISORDERS COMPRISING SPINOSIN	2017-03-09
20170065628	Inhibitors of Human EZH2, and Methods of Use Thereof	2017-03-09
20170065629	Non-Reducing End Unsaturated Mannuronic Acid Oligosaccharides And Compositions Containing Same As Active Ingredient	2017-03-09
20170065630	EXTENDED PRODUCTION OF NITRIC OXIDE FROM A MICROENCAPSULATED NITRITE SALT AND AN AQUEOUS ACIDIFIED GEL	2017-03-09
20170065631	INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES	2017-03-09
20170065632	Method for Treating Age-Related Hearing Loss (ARHL)	2017-03-09
20170065633	JELLY-LIKE MEDICINAL COMPOSITION OF POTASSIUM IODIDE	2017-03-09
20170065634	Chlorite in the Treatment of Neurodegenerative Disease	2017-03-09
20170065635	METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY	2017-03-09
20170065636	MODIFIED CELLS AND METHODS OF THERAPY	2017-03-09
20170065637	COMPOSITIONS AND METHODS FOR TREATING A PATHOGENIC METABOLIC CONDITION OF THE GUT MICROBIOTA AND DERIVED DISEASES	2017-03-09
20170065638	REGENERATIVE CELL THERAPY FOR CENTRAL NERVOUS SYSTEM (CNS) DISORDERS AND PTSD	2017-03-09
20170065639	MESENCHYMAL STEM CELLS WITH ENHANCED IMMUNOSUPPRESSIVE CAPABILITY	2017-03-09
20170065640	In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs	2017-03-09
20170065641	Transdiscal Administration of Specific Inhibitors of Pro-Inflammatory Cytokines	2017-03-09
20170065642	SYNTHETIC CORNEA FROM RETINAL STEM CELLS	2017-03-09
20170065643	METHOD OF STEM CELL DELIVERY INTO THE BRAIN DURING CHRONIC DISEASE USING BLOOD BRAIN BARRIER PERMEABILIZERS	2017-03-09
20170065644	TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS	2017-03-09
20170065645	KRILL OIL PREPARATIONS AND THEIR USES	2017-03-09
20170065646	METHOD OF TREATING ANDROGEN DEFICIENCY IN WOMEN	2017-03-09
20170065647	COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES	2017-03-09
20170065648	Probiotics And Methods Of Use	2017-03-09
20170065649	THERAPEUTIC BACTERIOPHAGE COMPOSITIONS	2017-03-09
20170065650	RNA VIRUSES FOR IMMUNOVIROTHERAPY	2017-03-09
20170065651	PHARMACEUTICAL PRODUCTS FROM FUNGAL STRAINS	2017-03-09
20170065652	Phosphodiesterase-4 Inhibiting Phytochemical Compositions	2017-03-09
20170065653	Phosphodiesterase Inhibiting Phytochemical Compositions	2017-03-09
20170065654	Enhanced Herb or Food Product and Method	2017-03-09
20170065655	MUTANT TOMATOES AND USE THEREOF FOR PREVENTING WEIGHT GAIN AND/OR TREATING OBESITY-RELATED CONDITIONS	2017-03-09
20170065656	SKIN CARE FORMULATION	2017-03-09
20170065657	COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH	2017-03-09
20170065658	COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH	2017-03-09
20170065659	COMPOSITION FOR USE IN TREATING AND/OR PREVENTING HUMAN CONDITION, DISORDER OR DISEASES	2017-03-09
20170065660	NUTRACEUTICAL COMPOSITION AND METHOD OF USE THEREOF	2017-03-09
20170065661	CHINESE MEDICINE PRESCRIPTION CAPABLE OF TREATING LUNG ADENOCARCINOMA	2017-03-09
20170065662	COMPOSITIONS TARGETING THE INTERACTION DOMAIN BETWEEN P27KIP1 AND BRK AND METHODS OF USE THEREOF TO INHIBIT P27 Y PHOSPHORYLATION AND CDK4 ACTIVITY	2017-03-09
20170065663	SUBSTANCE AND METHOD FOR TREATING INFLUENZA	2017-03-09
20170065664	USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES	2017-03-09
20170065665	LACTOCOCCUS LACTIS STRAINS	2017-03-09
20170065666	LACTOCOCCUS LACTIS STRAINS	2017-03-09
20170065667	METHODS FOR SYNCHRONIZATION OF ESTROUS CYCLES AND OVULATION FOR FIXED TIME ARTIFICIAL INSEMINATION IN CATTLE	2017-03-09
20170065668	PAR-1 Activation by Metalloproteinase-1 (MMP-1)	2017-03-09
20170065669	ANTITHROMBOTIC NANOPARTICLE	2017-03-09
20170065670	METHODS FOR TREATING IMMUNE MEDIATED NEUROLOGICAL DISEASES	2017-03-09
20170065671	METHODS FOR PRODUCING AN ORALSUSPENSION OF TEICHOPLANIN OR TEICHOPLANIN ANALOGS	2017-03-09
20170065672	USES OF STARCH BINDING PROTEIN (SBP)-TAGGED IMMUNOSTIMULATORY PROTEIN	2017-03-09
20170065673	NANOPARTICLE AGGREGATES CONTAINING OSTEOPONTIN AND CALCIUM- AND/OR STRONTIUM-CONTAINING PARTICLES	2017-03-09
20170065674	HYPOXIA-INDUCED MITOGENIC FACTOR	2017-03-09
20170065675	ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF	2017-03-09
20170065676	BPI AND ITS CONGENERS AS RADIATION MITIGATORS AND RADIATION PROTECTORS	2017-03-09
20170065677	EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT	2017-03-09
20170065678	METHODS OF TREATING METABOLIC DISORDERS ASSOCIATED WITH LIPODYSTROPHIES AND DEFECTS IN INSULIN PRODUCTION OR SIGNALING	2017-03-09
20170065679	TREATMENT OF DIABETES USING G-CSF	2017-03-09
20170065680	AGENT FOR THE TREATMENT OF ALOPECIA	2017-03-09
20170065681	USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS	2017-03-09
20170065682	USES OF A PTHrP ANALOGUE IN REDUCING FRACTURE RISK	2017-03-09
20170065683	STABLE FACTOR VIII FORMULATIONS WITH LOW SUGAR-GLYCINE	2017-03-09
20170065684	PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS	2017-03-09
20170065685	SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE	2017-03-09
20170065686	Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV	2017-03-09
20170065687	CHEMICALLY MODIFIED CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA	2017-03-09
20170065688	COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE	2017-03-09
20170065689	VACCINES	2017-03-09
20170065690	Tscm CELLS AND METHODS FOR USE	2017-03-09
20170065691	BRAIN CANCER IMMUNOTHERAPY	2017-03-09
20170065692	USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER	2017-03-09
20170065693	Sequential administration of a replication defective adenovirus vector in vaccination protocols	2017-03-09
20170065694	PEPTIDE VACCINE COMPRISING MUTANT RAS PEPTIDE AND CHEMOTHERAPEUTIC AGENT	2017-03-09
20170065695	LIVE ATTENUATED EDWARDSIELLA ICTALURI VACCINE AND METHOD OF USING THE SAME	2017-03-09
20170065696	NOVEL METHOD FOR PREVENTING OR TREATING M TUBERCULOSIS INFECTION	2017-03-09
20170065697	NOVEL COMPOSITIONS AND METHODS	2017-03-09
20170065698	VIRULENCE FACTORS OF STREPTOCOCCUS PNUEMONIAE	2017-03-09
20170065699	GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis	2017-03-09
20170065700	VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE	2017-03-09
20170065701	Process for Preparing an Attenuated Tetravalent Dengue Vaccine	2017-03-09
20170065702	METHODS OF MODULATING AN IMMUNE RESPONSE	2017-03-09

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees